Erector Spinae Plane Block (ESPB): in Patients Undergoing Surgery Through a Flank or Anterior Subcostal Incision.

NCT03691935 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-02-10

Study results available
· View outcomes & findings →

Summary

Using a randomized double-blinded study design, the study goal is to evaluate the superiority of Erector Spinae Plane block (ESPB) in the peri-operative pain management of patients undergoing surgery through a flank or anterior subcostal incision as compared to the standard of care of using IV and oral opiates.

Conditions

  • Nephrectomy
  • Partial Nephrectomy
  • Incision Site Discomfort

Interventions

DRUG

Ropivacaine

Erector Spinae Block with ropivacaine infusion with standard of care analgesics for perioperative pain control

DRUG

Normal saline

Erector Spinae Block with saline infusion with standard of care analgesics for for perioperative pain control

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Alireza Aminsharifi, M.D. · Milton S. Hershey Medical Center

  • Sanjib Adhikary, M.D. · Milton S. Hershey Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-28
Primary Completion
2024-01-19
Completion
2024-02-02
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03691935 on ClinicalTrials.gov